Search Results
The default setting for search results displays All Content. If you prefer to see recent content only, please adjust the date filter.
Filter your results:
Types
Topics
295 Results Found
AHA urges FTC to investigate certain pharmacy benefit manager practices
AHA today urged the FTC to scrutinize commercial health plans that steer patients to third-party specialty pharmacies in which they have a financial interest.
ASHRM 2022 Virtual Conference
The ASHRM 2022 Virtual Conference delivers key takeaways from ASHRM 2022 Boston.
Anthem Indiana’s ED “Downgrade” Policy Found to “Clearly” Violate Federal Law
An arbitrator has ordered that Anthem Insurance Company, Inc. (“Anthem”) pay a group of 11 acute care hospitals in Indiana (“hospitals”) $4.5 million as compensation for adopting a policy of processing claims for emergency services that the arbitrator found is a “clear” violation of federal and state law.
FDA issues update on COVID-19 treatments, hemodialysis machine risk
FDA issues updates on a COVID-19 monoclonal antibody and antiviral pill, and certain Fresenius Medical Care hemodialysis machines.
FDA: Medtronic heart device could malfunction
Medtronic this week alerted health care providers to a defect in its Heartware Ventricular Assist Device System that may cause the internal pump to malfunction.
'Take Back Day' Saturday to dispose safely of prescription drugs
DEA offers posters and other materials to help hospitals and other partners promote the event in their community.
FDA alerts providers to airway device safety risk
The agency has received reports describing serious adverse events and deaths after ventilation failure using silicone-based electromyogram endotracheal tubes.
ASHRM Express - Risk Management Education
Registration is open for ASHRM Express 2022, a summer professional education program for emerging health care risk management professionals.
FDA issues duodenoscope safety recommendations
The agency recommends health care facilities that still use fixed endcap duodenoscopes complete their transition to newer models that can lower infection risks.
FDA alerts providers to endoscope recall, reprocessing change
The Food and Drug Administration yesterday alerted health care providers to a recall and change in reprocessing methods for certain urological endoscopes made by Karl Storz.